Global Health Limited announced its entry into the North East with its plan to establish a super speciality hospital in Guwahati. The Board of Directors, in its meeting held today, approved the purchase of 3 acres of land from Assam Electricity Grid Corporation Ltd. for Rs. 30 crore plus incidental expenses for registration and possession of the land.
The Board has also approved plans to invest approximately Rs. 500 crores including cost of land in developing a state-of-the-art, 400-bed super specialty hospital. Proposed site is strategically located on National Highway 27, offering seamless connectivity across the entire North East region.
This expansion aims to strengthen healthcare infrastructure and will serve over 50 million people across Assam and its neighbouring states. Medanta's foray into the region will be transformative, bringing world-class medical expertise, cutting-edge technology and comprehensive care across more than 20 super specialties, including transplants and advanced robotic procedures.
Global Health Limited (Medanta) is an India-based multi-specialty tertiary care provider in the North and East regions of India. Medanta delivers advanced, end-to-end healthcare in Delhi, Gurugram, Indore, Ranchi, Patna, and Lucknow through its network of approximately five hospitals. The Company provides healthcare services in over 30 medical specialties and engages over 1,700 doctors, which is led by experienced department heads. Its speciality treatments are in cardiac care, cancer care, neurosciences, gastrosciences, orthopedics, renal care, liver transplant, oncology, bone marrow transplant, obstetrics and gynecology, chest surgery, lung transplant, pediatric care, and others. Its facilities and services include medicine delivery, lab tests & diagnostics, book homecare services, elder care, air ambulance, and among others. The Companyâs subsidiaries are Global Health Patliputra Private Limited, Medanta Holdings Private Limited, and GHL Pharma & Diagnostic Private Limited.
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
